Clinical Outcome of TAVI vs. SAVR in Patients with Severe Aortic Stenosis

Chayakrit Krittanawong; Hafeez Ul Hassan Virk; Joshua Hahn; Zhen Wang; Fu'ad Al-Azzam; Mahboob Alam; Samin Sharma; Hani Jneid

doi:10.3390/jcm12165236

Clinical Outcome of TAVI vs. SAVR in Patients with Severe Aortic Stenosis

J Clin Med. 2023 Aug 11;12(16):5236. doi: 10.3390/jcm12165236.

Authors

Chayakrit Krittanawong¹, Hafeez Ul Hassan Virk², Joshua Hahn³, Zhen Wang^{4

5}, Fu'ad Al-Azzam⁶, Mahboob Alam⁷, Samin Sharma⁸, Hani Jneid³

Affiliations

¹ Cardiology Division, New York University Langone Health and New York University School of Medicine, New York, NY 10016, USA.
² Harrington Heart & Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.
³ Division of Cardiology, University of Texas Medical Branch, Houston, TX 77059, USA.
⁴ Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN 55905, USA.
⁵ Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
⁶ Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN 55905, USA.
⁷ The Texas Heart Institute, Baylor College of Medicine, Houston, TX 77030, USA.
⁸ Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Hospital, New York, NY 10029, USA.

Abstract

The utilization of transcatheter aortic valve implantation (TAVI) has become the treatment of choice in patients with severe aortic stenosis (AS) with intermediate-to-high surgical risk for surgical aortic valve replacement (SAVR) [...].

Publication types

Editorial